drugset / Trial / NCT00906087

Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions

NCT00906087

NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to determine if one of the genes that can cause glaucoma, called myocilin, are associated with larger eye pressure and blood pressure changes in sitting and lying down positions without glaucoma drug treatment and with glaucoma drug treatment with a combination medication called Cosopt® (Merck \& Co., Inc.).

Timeline

Start
2009-08-04
Primary completion
2012-07-18
Completion
2012-07-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule Topical
Subject Timolol Other / unclassified Topical

Indications